Exagen EV - Enterprise Value 2011-2026 | XGN

Annual EV - Enterprise Value Exagen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
78.4 M	72.3 M	29 M	21.7 M	60.5 M	178 M	41.1 M	22.4 M	25 M	-	36.8 M	31.2 M	16 M	6.44 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
178 M	6.44 M	47.6 M

EV - Enterprise Value of other stocks in the Diagnostics research industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-19.1 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	1.64 B	-	-17.87 %	$ 25.9 M	Canada
Bioventus BVS	1.01 B	$ 8.98	1.18 %	$ 598 M	USA
Brainsway Ltd. BWAY	223 M	$ 13.87	1.61 %	$ 99.4 M	Israel
Castle Biosciences CSTL	665 M	$ 26.0	0.64 %	$ 722 M	USA
Aspira Women's Health AWH	42.8 M	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	28.2 B	$ 68.09	2.64 %	$ 26.6 B	USA
Guardant Health GH	15.2 B	$ 88.7	1.74 %	$ 11.1 B	USA
Oxford Immunotec Global PLC OXFD	26.2 M	-	-	$ 562 M	Britain
Charles River Laboratories International CRL	11.4 B	$ 155.4	2.26 %	$ 7.7 B	USA
CareDx, Inc CDNA	1.04 B	$ 17.57	1.44 %	$ 936 M	USA
ICON Public Limited Company ICLR	26.4 B	$ 101.48	3.96 %	$ 8.37 B	Irlanda
IQVIA Holdings IQV	49.6 B	$ 169.45	2.77 %	$ 29.1 B	USA
Accelerate Diagnostics AXDX	92.6 M	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	22 B	$ 103.94	0.08 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	-2.77 B	-	-	$ 399 M	China
Fluidigm Corporation FLDM	6.64 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	9.21 B	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	251 M	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	502 M	$ 15.65	4.65 %	$ 473 M	USA
PRA Health Sciences, Inc. PRAH	5.02 B	-	-	$ 10.7 B	USA
Biodesix BDSX	142 M	$ 17.5	1.21 %	$ 2.27 B	USA
Anixa Biosciences ANIX	990 K	$ 2.88	1.23 %	$ 93.5 K	USA
Neogen Corporation NEOG	2.26 B	$ 9.37	2.85 %	$ 2.03 B	USA
Danaher Corporation DHR	145 B	$ 194.76	1.76 %	$ 139 B	USA
Biocept BIOC	15 M	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	851 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	3.16 M	-	-20.0 %	$ 1.06 M	USA
Pacific Biosciences of California PACB	1.21 B	$ 1.4	3.16 %	$ 420 M	USA
Illumina ILMN	15.3 B	$ 121.73	2.05 %	$ 19.4 B	USA
Quest Diagnostics Incorporated DGX	22.9 B	$ 199.39	0.23 %	$ 22.1 B	USA
QIAGEN N.V. QGEN	11.3 B	-	-	$ 10.6 B	Niderland
Agilent Technologies A	45.8 B	$ 113.69	1.66 %	$ 34.6 B	USA
BioNano Genomics BNGO	35.7 M	$ 1.12	0.9 %	$ 1.42 M	USA
DarioHealth Corp. DRIO	6.61 M	$ 9.28	10.24 %	$ 263 M	Israel
Lantheus Holdings LNTH	5.9 B	$ 78.71	0.26 %	$ 5.31 B	USA
Chembio Diagnostics CEMI	39.2 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	2.55 M	-	-	$ 9.42 M	Israel
Co-Diagnostics CODX	29.3 M	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	14 B	$ 457.78	0.91 %	$ 13.2 B	USA
Motus GI Holdings MOTS	568 K	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	32.1 B	$ 1 218.18	1.62 %	$ 25.1 B	Schweiz
Celcuity CELC	506 M	$ 114.64	-0.23 %	$ 4.52 B	USA
DermTech DMTK	70.4 M	-	-11.32 %	$ 2.94 M	USA
Twist Bioscience Corporation TWST	1.55 B	$ 46.28	2.82 %	$ 2.77 B	USA
National Research Corporation NRC	432 M	$ 18.07	3.85 %	$ 404 M	USA
NeoGenomics NEO	1.85 B	$ 8.41	2.06 %	$ 1.08 B	USA
Invitae Corporation NVTA	2.11 B	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	-22.7 M	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	5.53 B	$ 201.38	1.87 %	$ 19.8 B	USA